The addition of brentuximab vedotin to lenalidomide and rituximab extended survival among heavily pretreated patients with ...

City of Springfield snowplow drivers are working nonstop to clear the roads, but even using tons of salt is limited in what ...

Bernstam, MD, discusses updated findings from the phase 1 TROPION-PanTumor01 study of datopotamab deruxtecan-dlnk in heavily ...

The Texas Department of Transportation (TxDOT) pretreated roads in anticipation of potential winter weather this week, using ...

Cardiovascular mortality risk in primary penile cancer patients: A retrospective cohort study from 2000 to 2021. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium.

Casdatifan, an HIF-2α inhibitor, showed a 33% objective response rate in ccRCC patients at a 100 mg daily dose. The drug targets hypoxia-inducible factor-2 alpha to disrupt tumor-promoting ...